|
A.T. Still University of Health Sciences - School of Osteopathic Medicine in Arizona and Kirksville College of Osteopathic Medicine | |
| City: Mesa and Kirksville | State: AZ and MO | |
|
Links:
Updates: This institution's COI policies were evaluated on Oct-19 -2016. This institution submitted policies for review for the 2016 AMSA Scorecard. |
||
| Gifts |  |
Never specifically mentioned, but uses the term 'financial interest' which classifies anything of monetary value. This may also apply for domain 2 (meals). Only disclosure is required. No mention of restrictions. [Domain Location: 32a, pg 3] |
| Meals | |
As in domain 1, only disclosures are outlined. No mention of anything prohibited. [Domain Location: 32a, pg 3] |
| Industry-funded promotional speaking relationships (not ACCME-accredited) | |
No mention on speaking relationships. However Under definitions, they exclude income from seminars, lectures, or travel reimbursed/sponsored by excluded sources provided in the regulation in the definition of 'significant financial interest.' [Domain Location: 32a, pg 2] |
| Industry-support of ACCME-accredited CME | |
No section on CME [Domain Location: ] |
| Attendance of industry-sponsored promotional events | |
No section on industry-sponsored promotional program attendance. [Domain Location: ] |
| Industry-supported scholarships and awards |  |
There is a section on making sure there is an MOU to manage potential COIs that is approved by institutional official. [Domain Location: 32a, pg 5] |
| Ghostwriting and honorary authorships | |
Paid authorship is included in the definition for significant financial interest (SFI) and remuneration. SFIs must be disclosed and the institutional official and conflict of interest review committee (CIRC) determines if it is a financial conflict of int [Domain Location: defined on 32a, pg 2] |
| Consulting and advising relationships | |
Again, it must disclosed or pre-disclosed and then there is a meeting to determine next steps. It does not say SFIs are prohibited or on what stipulation they are allowed. [Domain Location: defined in 32a, pg 2] |
| Access of pharmaceutical sales representatives | |
No mention of access of Pharm Reps [Domain Location: ] |
| Access of medical device representatives | |
No mention or section on access of medical device reps [Domain Location: ] |
| Conflict of interest disclosure |  |
Disclosure must be made and is reviewed by a head, who then refers to a committee, who then meets in private. They specifically state meetings are closed to the public. [Domain Location: 32a, pg 4] |
| COI curriculum | |
Required for medical students, but cannot adequately gauge the efficacy without looking at what they covered, which was not provided. [Domain Location: 32z, pg 1] |
| Extension of COI policies to community affiliates | |
Only to the extent that they might be pursuing research involving students/residents. [Domain Location: 32z, pg 1] |
| Enforcement and Sanctions of Policies | |
There is a committee (CIRC) that determines sanctions against potential FCOI. [Domain Location: 32a, pg 4] |
 | |
| Model policy |
| Good progress toward model policy |
| No policy, or policy unlikely to have a substantial effect on behavior |
